For instance, elevated sVEGFR-1 levels (a decoy receptor for VEGF-A) correlate with endothelial dysfunction and thromboembolic complications in AF patients, implying that excessive VEGF suppression compromises vascular integrity [4,34]. The gene discussed is VEGFA; the disease is atrial fibrillation.